3 days ago
Ripple Stablecoin RLUSD Is A ‘Trojan Horse’ For DeFi And Banking, Claims Venture Capitalist
In his latest video analysis on YouTube, Adam Cochran, partner at Cinneamhain Ventures (CEHV), an activist venture capital firm, described…
2 weeks ago
Ripple CEO Announces Approval For RLUSD Stablecoin By New York Regulators
On Tuesday, Ripple CEO Brad Garlinghouse revealed that the New York State Department of Financial Services (NYSDFS) has granted final…
2 weeks ago
Ripple CEO on 60 Minutes: Garlinghouse Opens Up on $150 Million SEC Fight, Crypto War And More
Ripple CEO Brad Garlinghouse appeared in an interview on 60 Minutes, airing on December 8, 2024, where he discussed the…
2 weeks ago
XRP Price Jumps as David Sacks to Favour Ripple in SEC Lawsuit
XRP Price Rises: David Sacks to Favor Ripple? Speculations are rising about the XRP lawsuit as yet another pro-crypto David…
2 weeks ago
Ripple CEO to appear on 60 Minutes this Sunday
Garlinghouse took to the X social media network to announce the official date earlier today. The interview, which was initially…
3 weeks ago
XRP Experiencing A Leverage-Driven Rally – What This Means To Price
XRP has surged past the $1.62 level, placing it less than 5% away from the crucial $2 mark. This impressive…
3 weeks ago
Ripple Labs Nears New York Approval For Stablecoin Launch In US Crypto Market
Ripple Labs is on the verge of receiving approval from New York’s top crypto regulator for its new stablecoin, RLUSD.…
4 weeks ago
Ripple CLO Stuart Alderoty Challenges US SEC
Ripple CLO Stuart Alderoty slammed the U.S. Securities and Exchange Commission (SEC) for bragging about enforcement actions and raising record…
2024-11-16
Why XRP could hit $8+
XRP has emerged from what can be considered a hibernation, with the token reclaiming the $1 mark for the first…
2024-11-16
Ripple CEO Claims Trump’s Election Unlocked $800 Billion in US Crypto Industry
In a recent interview with Fox Business, Ripple CEO Brad Garlinghouse praised Trump’s potential impact on crypto. Specifically, he claimed…